Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.11% slipped 0.48% to $166.77 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.53% rising 0.23% to 4,283.74 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.29% rising 0.06% to 33,999.04. The stock's fall snapped a three-day winning streak. Johnson & Johnson closed $19.92 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +6.36% rose 2.64% to $334.10, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.66% rose 0.40% to $91.40, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.36% fell 1.40% to $48.58. Trading volume (8.3 M) eclipsed its 50-day average volume of 6.8 M.